Covidien (COV) PT Bumped to $97 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray bumped its price target on Neutral-rated Covidien Ltd (NYSE: COV) to $97.00 (from $95.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE